Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Biliary Tract Adenocarcinoma × donafenib × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 18 Liver Neoplasms 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Carcinoma 2 Recurrence 1 Pancreatic Neoplasms 1 Esophageal Neoplasms 1 Digestive System Neoplasms 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Biliary Tract Carcinoma 1 Biliary Tract Adenocarcinoma 1 Biliary Malignant Tumors 1

Interventions

toripalimab 1 donafenib 1 Oxaliplatin 1 HMPL-013 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05350943 2022-10-18

HAIC Combined With Toripalimab and Donafenib for Advanced BTC

Fudan University

Phase 2 Unknown

Gastrointestinal

Biliary Tract Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡